Compare BDSX & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | HCKT |
|---|---|---|
| Founded | 2005 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.2M | 249.5M |
| IPO Year | 2020 | 1998 |
| Metric | BDSX | HCKT |
|---|---|---|
| Price | $23.46 | $11.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $39.00 | $16.67 |
| AVG Volume (30 Days) | 93.2K | ★ 155.5K |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 4.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.34 |
| Revenue | $88,499,000.00 | ★ $285,862,000.00 |
| Revenue This Year | $26.51 | N/A |
| Revenue Next Year | $20.25 | $3.57 |
| P/E Ratio | ★ N/A | $33.24 |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $5.26 | $9.16 |
| 52 Week High | $31.97 | $20.68 |
| Indicator | BDSX | HCKT |
|---|---|---|
| Relative Strength Index (RSI) | 39.96 | 56.88 |
| Support Level | $19.26 | $9.83 |
| Resistance Level | $24.82 | $11.59 |
| Average True Range (ATR) | 1.88 | 0.34 |
| MACD | -0.55 | 0.09 |
| Stochastic Oscillator | 18.99 | 75.25 |
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.